Biofrontera AG is a biopharmaceutical company that researches, develops, and distributes dermatological and medical products in Germany, Spain, the United Kingdom, the rest of Europe, the United States, and internationally. Its offerings include Ameluz and the BF-RhodoLED lamp for treating mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. It also provides the RhodoLED XL lamp for multiple interspersed lesions and Belixos, a cosmetic product for irritated and sensitive skin. The company focuses on photodynamic therapy (PDT) for actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma, and has a license and supply agreement with Maruho Co., Ltd. Founded in 1997, Biofrontera AG is headquartered in Leverkusen, Germany.